会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases
    • 7-氨基-2-烷基硫代蝶啶-4-基胺,用于治疗趋化因子相关疾病
    • US07071193B2
    • 2006-07-04
    • US10399570
    • 2001-10-16
    • Roger BonnertIain Walters
    • Roger BonnertIain Walters
    • A01N43/58A01N43/60A61K31/50A61K31/495C07D239/00
    • C07D475/06
    • Pteridine compounds of formula (I) processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in the treatment of inflammatory diseases such as psoriasis, rheumatoid arthritis, diseases in which angiogenesis is assocated with raised CXCR2 chemokine levels (diabetic retinopathy) and COPD. The compounds are ligands for chemokine receptors and medical indications mentioned in the description include: diseases of the respiratory tract (COPDD, asthma, bronchitis, rhinitis, fibroid lung, pneumonia, etc.), diseases of the bones and joints (arthritis, etc.), skin-diseases (psoriasis, etc), diseases of the gastrointestinal tract, diseases in other tissues and systemic disease (multipe sclerosis, atherosclerosis, AIDS, type 1 diabetes, leprosy, sepsis, etc.), allograft rejection, cancers, cystic fibrosis, stroke, burn wounds, skin ulcers, reproductive disease and more.
    • 式(I)的蝶啶化合物及其制备中使用的中间体,含有它们的药物组合物及其用于治疗炎性疾病如牛皮癣,类风湿性关节炎,血管发生与升高的CXCR2趋化因子水平(糖尿病性视网膜病变)相关的疾病, 和COPD。 这些化合物是趋化因子受体的配体,描述中提及的医学指征包括:呼吸道疾病(COPDD,哮喘,支气管炎,鼻炎,纤维瘤肺,肺炎等),骨骼和关节疾病(关节炎等) ),皮肤病(牛皮癣等),胃肠道疾病,其他组织中的疾病和全身性疾病(多发性硬化,动脉粥样硬化,艾滋病,1型糖尿病,麻风病,败血症等),同种异体移植物排斥反应,癌症,囊性 纤维化,中风,烧伤,皮肤溃疡,生殖疾病等。